Home NDC 60505-3518-06 NDC 60505-3518-06 - Levetiracetam This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 60505-3518
Requested NDC 60505-3518-06
Package NDCs from labels 60505-3518-6, 60505-3518-06
Manufacturer Apotex Corp. | Apotex Inc.
Effective date 2026-09-14
Current FDA listing Not matched in FDA.report NDC product tables
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 60505-3518-6 Levetiracetam 60 in 1 BOTTLE TABLET, FILM COATED, EXTENDED RE 60 20
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 60505-3518 LEVETIRACETAM TABLET, FILM COATED, EXTENDED RELEASE [APOTEX CORP.] 19 Current NDC, Legacy NDC, 1 package rows 20241012_abc9fada-c5c2-4e07-fb8a-4d1518f7657e.zip
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded LEVETIRACETAM ACTIVE INGREDIENT 44YRR34555 LEVETIRACETAM TABLET, FILM COATED, EXTENDED RELEASE [APOTEX CORP.] 7 LEVETIRACETAM ACTIVE MOIETY 44YRR34555 LEVETIRACETAM TABLET, FILM COATED, EXTENDED RELEASE [APOTEX CORP.] 7 Hydroxypropyl Cellulose (Type H) INACTIVE INGREDIENT RFW2ET671P LEVETIRACETAM TABLET, FILM COATED, EXTENDED RELEASE [APOTEX CORP.] 7 HYPROMELLOSE 2208 (15000 MPA.S) INACTIVE INGREDIENT Z78RG6M2N2 LEVETIRACETAM TABLET, FILM COATED, EXTENDED RELEASE [APOTEX CORP.] 7 HYPROMELLOSE 2910 (5 MPA.S) INACTIVE INGREDIENT R75537T0T4 LEVETIRACETAM TABLET, FILM COATED, EXTENDED RELEASE [APOTEX CORP.] 7 POLYETHYLENE GLYCOL 8000 INACTIVE INGREDIENT Q662QK8M3B LEVETIRACETAM TABLET, FILM COATED, EXTENDED RELEASE [APOTEX CORP.] 7 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 LEVETIRACETAM TABLET, FILM COATED, EXTENDED RELEASE [APOTEX CORP.] 7 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP LEVETIRACETAM TABLET, FILM COATED, EXTENDED RELEASE [APOTEX CORP.] 7 WATER INACTIVE INGREDIENT 059QF0KO0R LEVETIRACETAM TABLET, FILM COATED, EXTENDED RELEASE [APOTEX CORP.] 7
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 141 · 2,803 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Levetiracetam LEVETIRACETAM REMEDYREPACK INC. 46852061-e59a-4a8c-aba0-ce4c7887f366 2026-11-06 Warnings, Adverse reactions Exact identifier unii: 44YRR34555 Levetiracetam LEVETIRACETAM PD-Rx Pharmaceuticals, Inc. c2177034-e164-453c-be02-1cf91ce27a07 2026-11-05 Warnings, Adverse reactions Exact identifier unii: 44YRR34555 COOLA 70 PERCENT PLUS ORGANIC MINERAL BODY SUNSCREEN SPF50 TITANIUM DIOXIDE, ZINC OXIDE COOLA, LLC cb95c712-1680-4040-e053-2995a90af004 2026-11-04 Warnings Exact identifier unii: 15FIX9V2JP Vertra Ehukai Beige Sunscreen Face Stick Broad Spectrum SPF 38 TITANIUM DIOXIDE Eai-jr 286, Inc 303d5d5a-4c7a-1e23-e063-6294a90a0e58 2026-11-04 Warnings Exact identifier unii: 15FIX9V2JP Vertra Mick Fanning Signature Foundation Sunscreen Face Stick SPF 35 Coolangatta Beige TITANIUM DIOXIDE EAI-JR 286, Inc. b9ea12e8-6ed9-d805-e053-2a95a90aa107 2026-11-04 Warnings Exact identifier unii: 15FIX9V2JP Vertra Pearl White Face Stick SPF 50 PADIMATE O, TITANIUM DIOXIDE Eai-jr 286, Inc b69a75e0-8724-35ae-e053-2a95a90a5f34 2026-11-04 Warnings Exact identifier unii: 15FIX9V2JP Vertra S Dorian Kona Gold Signature Face Stick SPF 38 TITANIUM DIOXIDE Eai-jr 286, Inc b6c316c3-661b-6428-e053-2a95a90a1a6b 2026-11-04 Warnings Exact identifier unii: 15FIX9V2JP Levetiracetam LEVETIRACETAM Civica, Inc. 1591c690-f4ed-44b7-a9d0-bff1fbb4bfef 2026-11-03 Warnings, Adverse reactions Exact identifier unii: 44YRR34555 HERA SILKYSTAY FOUNDATION 34W1 TITANIUM DIOXIDE Amorepacific Corporation 5f3ef340-c68e-1790-e063-6394a90a44aa 2026-11-01 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 35C1 TITANIUM DIOXIDE Amorepacific Corporation 5f40c97f-b90e-bec7-e063-6394a90ae5db 2026-11-01 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 35N1 TITANIUM DIOXIDE Amorepacific Corporation 5f40f46b-c6b2-df1f-e063-6394a90afd96 2026-11-01 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 37W1 TITANIUM DIOXIDE Amorepacific Corporation 5f4105f3-d08b-edb5-e063-6394a90ad28b 2026-11-01 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 39N1 TITANIUM DIOXIDE Amorepacific Corporation 5f41120a-521a-f5ac-e063-6394a90ac021 2026-11-01 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 41W1 TITANIUM DIOXIDE Amorepacific Corporation 5f4158f0-c743-29c2-e063-6394a90ac721 2026-11-01 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 43N1 TITANIUM DIOXIDE Amorepacific Corporation 5f41ecb2-9fe5-ade7-e063-6294a90abc4e 2026-11-01 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 43O1 TITANIUM DIOXIDE Amorepacific Corporation 5f425415-ed84-fc33-e063-6394a90a15f7 2026-11-01 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 44C1 TITANIUM DIOXIDE Amorepacific Corporation 5f42d960-6b86-b4cd-e063-6294a90a98f3 2026-11-01 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 45N1 TITANIUM DIOXIDE Amorepacific Corporation 5f4326fc-b3c3-1a8b-e063-6294a90a8d9b 2026-11-01 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 45W1 TITANIUM DIOXIDE Amorepacific Corporation 5f4335c8-596f-3269-e063-6294a90a6c3d 2026-11-01 Warnings Exact identifier unii: 15FIX9V2JP HERA SILKYSTAY FOUNDATION 46W1 TITANIUM DIOXIDE Amorepacific Corporation 5f43404e-bdab-3f4b-e063-6294a90ab881 2026-11-01 Warnings Exact identifier unii: 15FIX9V2JP
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.